Introduction: Henoch Schonlein Purpura (HSP) is the most common systemic vasculitis in children. The objectives of the present study were to describe the clinical profile, complications and management modalities of children with HSP in North Kerala  and also to follow  them up for a minimum period of six months after diagnosis with special emphasis on renal involvement

Materials and Methods: It is a hospital based descriptive follow-up study conducted at a major tertiary care teaching hospital under government sector in North Kerala.  64 children less than 12 years diagnosed to have HSP according to the European League against Rheumatism criteria were included.  The clinical features, laboratory investigations, management and complications of the disease were studied, and all children were followed up for a minimum period of six months. Descriptive statistics was used to analyse the results.

Results: The mean age was 7.84± 2.69 years with a male female ratio of 1.06:1. The predominant clinical features of HSP were cutaneous purpura (100%), arthritis (82.8%), abdominal symptoms (70.3%), and renal involvement (23.5%).Six children developed renal involvement two weeks after the onset of rash. 15 children (23.5%) had recurrence during the initial six months. 23 (%)children were treated with steroids

Conclusions: Equal sex predilection and relatively lower incidence of renal involvement were seen in the present study. Follow up for more time is needed to identify more incidence of renal involvement. Treatment with steroids did not alter the occurrence of renal involvement or recurrence in this study

Keywords: HSP, children, clinical features, renal involvement, follow up.

1. Paul Brogan and Aravind Bagga. Leucocytoclastic vasculitis. In: Ross E. Petty et al. editor. Textbook of Paediatric Rheumatology. 7th edition. Saunders Philadelphia. 2016; 452-459.
2. Stacy P, Ardoin and Edward Fels. Vasculitis syndromes. In: Kliegman RM, et al editors. Nelson Textbook of Paediatrics, 20^th Saunders Philadelphia. 2016: 1215-1217.
3. Ozen S et al. The EULAR/PRINTO/PRES criteria for Henoch Schonlein purpura. Ann Rheum Dis.2010; 798-806
4. Narchi, Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings : a systematic review, Arch. Dis. Child. 90 (2005) 916–920.
5. Abbas S, Geetha S, Deepthi RV, Kamar J, Uthup S. Clinical profile and outcome of Henoch Schonlein purpura in a tertiary care hospital in South India. Int J Contemp Pediatr 2017; 4:822-6.
6. Albaramki J.Henoch-Schonlein purpura in childhood a fifteen-year experience at a tertiary hospital. J Med Liban. 2016 Jan-Mar;64(1):13-7.
7. Lardhi AA Henoch-Schonlein purpura in children from the eastern province of Saudi Arabia Saudi Med J. 2012 Sep;33(9):973-8.
8. Bagga A, Kabra SK, Srivastava RN, Bhunyan UN. Henoch Schonlein purpura in North Indian children. Indian Pediatrics 1991; 28:1153 -1157.
9. Saulsbury FT. Henoch-Schönlein purpura in children: report of 100 patients and review of the literature. Medicine. 1999; 78:395-409.
10. Lata Kumar, Surjit Singh, et al. Henoch Schonlein Purpura: The Chandigarh experience. Indian Pediatrics 1998; 35: 19-25.
11. Anil M, Aksu N, Kara OD, Bal A, Anil AB, Yavascan O et al. Henoch-Schonlein purpura in children from western Turkey: a retrospective analysis of 430 cases. Turk J Pediatr
12. Ballinger S: Henoch-Sch6nlein purpura. Curr Opin Rheumatol 15: 591-594. 2003
13. Grover N, Sankhyan N, Bisht JP. A five year review of clinical profile in Henoch Schonlein purpura. Journal of Nepal Medical Association 2007;46: 62 – 65.
14. Bagai A, Albert S, Shenoi SD. Evaluation and therapeutic outcome of palpable purpura. Indian Journal of Dermatology Venereology Leprology2001; 67:320-323.
15. Sarkar S, Mondel R, Nandi M, Ghosh A. Trends of childhood vasculitis inEastern India. Indian Pediatrics 2011; 48:814.
16. Stewart M, Savage JM, Bell B et al. Long term renal prognosis of Henoch Schonlein purpura in an unselected childhood population. Eur Journal of Pediatrics.1988; 147:1113- 1115
17. Evans Jones LG, Glough JV. Thrombocytosis in Henoch Schonlein purpura. Clin lab Hematology 1990; 12: 137- 139.
18. Mollica F, Li Volti S, Garazzo R, Rusio G. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Ped 1992; 151:140-144.
19. Den Boer SL, Pasmans S, Wulffraat NM, Ramakers-Van Woerden NL, Bousema MTBullous lesions in Henoch Schönlein Purpura as indication to start systemic prednisone.Acta Paediatr. 2010 May;99(5):781-783
20. Trapani S, Mariotti P, Resti M, Nappini L, de Martino M, Falcini F Severe hemorrhagic bullous lesions in Henoch Schonlein purpura: three pediatric cases and review of the literature. Rheumatol Int. 2010 Aug;30(10):1355-9.

Dr T G Sindhu

Associate Professor, Department of Paediatrics,

Government Medical College Kozhikode, Kozhikode, Kerala, India 673008

Phone No: 9846102548, 04952354633, Email: This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it.